Clinical Trial: Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest

Brief Summary: The objective of the trial is to investigate efficacy and safety of ingenol mebutate gel for actinic keratosis applied to large treatment areas once daily for three consecutive days on face, scalp or chest.

Detailed Summary:
Sponsor: LEO Pharma

Current Primary Outcome: Complete resolution of actinic keratosis (AK) [ Time Frame: 8 weeks ]

Complete resolution of actinic keratosis (AK) at Week 8, defined as 100% reduction from baseline in the number of clinically visible AKs


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: LEO Pharma

Dates:
Date Received: February 2, 2015
Date Started: April 2015
Date Completion:
Last Updated: April 12, 2017
Last Verified: April 2017